Oxidative stress: how protein recycling protects against cell death

View through the microscope: Cell undergoes ferroptosis | © Alexander Bartelt

Researchers at LMU University Hospital have discovered a new molecular switch that protects against cell death.

Programmed cell death protects the body against cancer and other diseases. A team of researchers led by Professor Alexander Bartelt from the Institute for Cardiovascular Prevention (IPEK) has decoded a new mechanism by which oxidative stress influences cell death. The researchers hope this discovery will lead to novel approaches for targeting cancer cells and other diseases. Their findings were recently published in the journal Cell Death & Differentiation.

When the lipids in the plasma are attacked, it is referred to as ferroptosis. In a chain reaction, the lipid molecules that make up the membrane are being destroyed and the cell literally dissolves.  “Ferroptosis is a recently discovered form of cell death and we’re searching for ways to control the process,” says Bartelt. The team concentrated on the proteasome, which functions as a sort of recycling bin for the cell. Through the operations of the proteasome, old or damaged proteins are broken down and made available to the cell again.

Using state-of-the-art methods of mass spectrometry, the team investigated whether the recycling of proteins is disrupted during ferroptosis. In this way, the researchers found that the proteasome is effectively clogged up, accelerating cell death. At the same time, they identified the enzyme DDI2, which cranks up the recycling again and protects against cell death. “DDI2 is a protease – a type of enzyme it’s possible to therapeutically influence,” says Anahita Ofoghi, who carried out the study.

The findings point to a new way of manipulating cell death. This could be relevant not only for new cancer therapies, but also indicates how we might be able to protect healthy cells against death. “We’ve contributed a small piece to the fascinating puzzle of ferroptosis,” says Bartelt. The authors now hope to exploit this molecular mechanism for therapies.

Journal: Cell Death and Differentiation
DOI: 10.1038/s41418-024-01398-z
Article Title: Activating the NFE2L1-ubiquitin-proteasome system by DDI2 protects from ferroptosis
Article Publication Date: 9-Oct-2024

Media Contact

Constanze Drewlo
Ludwig-Maximilians-Universität München
c.drewlo@lmu.de
Office: 089-218-06529

Expert Contact

Prof. Alexander Bartelt
Institute for Cardiovascular Prevention, LMU Klinikum
Alexander.Bartelt@med.lmu.de
Office: +49 89 4400 43905

Media Contact

Constanze Drewlo
Ludwig-Maximilians-Universität München

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Distance learning can improve women’s access to vocational training as animal health care practitioners in Nepal. Image Credit: Heifer International

Hybrid Job Training Boosts Women’s Participation in Nepal

Globally, women’s workforce participation is about 25% lower than men’s, often due to barriers such as domestic responsibilities and cultural norms. Vocational training can increase employment opportunities, but women may…

CO2release increase under repeated drying-rewetting cycles (DWCs). Image Credit: Suzuki, Nagano et al., 2025 SOIL

Drying and Rewetting Cycles Boost Soil CO2 Emissions

Niigata, Japan – The amount of carbon dioxide (CO2) released by microbial decomposition of soil organic carbon on a global scale is approximately five times greater than the amount of…

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers. Oregon State's Olena Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon Health & Science University, designed a type of drug nanocarrier known as a polymersome to specifically target a protein in choriocarcinoma cells. Depicted is a polymersome with its methotrexate cargo. Illustration by Parinaz Ghanbari. Image Credit: Parinaz Ghanbari

Improved Treatment Method for Rare Pregnancy-Related Cancer

PORTLAND, Ore. – A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other…